Are RGNT insiders buying or selling?

In the last 90 days, Regentis (RGNT) had 0 insider transactions. Track every executive trade, dollar amount, and date.

Which hedge funds own RGNT?

See every hedge fund and asset manager holding Regentis (RGNT).

How much of RGNT trades in dark pools?

Track Regentis (RGNT) dark pool activity and off-exchange block trades.

Regentis (RGNT) Smart Money — Insiders, Congress, Hedge Funds

$2.32

+0.45 (+24.39%)

Weekly Expected Move ±7.2%

$2 $2 $2 $2 $2

AMEX · Healthcare · Medical - Instruments & Supplies · Alpha Radar Sell · Power 38 · $7.3M mcap · 2M float · 0.265% daily turnover · Short 45% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Smart Money Score

No convergence signal

Key Statistics

Market Cap$7.3M

52W Range1.8201-8.35

Volume10,324

Avg Volume6,278

Beta1.42

Dividend—

Analyst Ratings

No analyst coverage

Company Info

CEOEhud Geller

Employees10

SectorHealthcare

IndustryMedical - Instruments & Supplies

IPO Date2025-09-11

Websiteregentis.co.il

60 Medinat Hayehudim Street
Herzliya 4676652
IL

972 9 960 1917

About Regentis Biomaterials Ltd.

Regentis Biomaterials Ltd., a regenerative medicine company, develops tissue repair solutions that restore the health and enhance quality of life of patients. Its lead product candidate is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries and articular knee cartilage. The company focuses on developing orthopedic treatments using its Gelrin platform that is based on degradable hydrogel implants to regenerate damaged or diseased tissue. Regentis Biomaterials Ltd. was incorporated in 2004 and is based in Herzliya, Israel.

Latest News